Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Invitae Corporation Common Stock (NY:NVTA)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Feb 5, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	0.0888 (12)
Ask (Size)	0.0896 (75)
Prev. Close	0.0891
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	217,339,666
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal ↗

April 25, 2024

Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's...

Via Benzinga

Softbank-Backed Cohesity To Acquire Veritas Data Security Unit For $3B: Report ↗

February 08, 2024

Cohesity, a U.S.-based data security software company, is set to acquire the data protection business of Veritas, a subsidiary of Carlyle Group.

Via Benzinga

Performance

More News

US Stocks Gain; Uber Posts Upbeat Sales ↗

February 07, 2024

Via Benzinga

The New York Stock Exchange Will Start Delisting Invitae (NVTA) Stock ↗

February 06, 2024

Via InvestorPlace

Why Is Agrify (AGFY) Stock Up 57% Today? ↗

February 06, 2024

Via InvestorPlace

Is Invitae Stock a Buy Now? ↗

January 29, 2024

Via The Motley Fool

Looking Into Invitae's Recent Short Interest ↗

January 18, 2024

Via Benzinga

(NVTA) - Analyzing Invitae's Short Interest ↗

January 01, 2024

Via Benzinga

NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy ↗

February 06, 2024

Via InvestorPlace

Why Is Invitae (NVTA) Stock Down 75% Today? ↗

February 05, 2024

Via InvestorPlace

SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy ↗

February 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 05, 2024

Via Benzinga

Invitae’s High-Stakes Financial Maneuvering: Dilution Might Not Be That Bad ↗

January 23, 2024

Via Talk Markets

Earnings Preview: Invitae ↗

November 07, 2023

Via Benzinga

Is Invitae Stock a Buy Now? ↗

November 01, 2023

Via The Motley Fool

Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle ↗

January 17, 2024

Via Investor's Business Daily

US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit ↗

December 28, 2023

Via Benzinga

Invitae Layoffs 2023: What to Know About the Latest NVTA Job Cuts ↗

December 15, 2023

Via InvestorPlace

Better Growth Stock: CRISPR Therapeutics vs. Invitae ↗

December 05, 2023

Via The Motley Fool

Invitae (NVTA) Q3 2023 Earnings Call Transcript ↗

November 09, 2023

Via The Motley Fool

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 09, 2023

Via Benzinga

3 Things About Invitae Every Smart Investor Knows ↗

November 04, 2023

Via The Motley Fool

3 Penny Stocks That Look Like Intriguing Bets for the Long-Term ↗

October 31, 2023

Via InvestorPlace

Why Invitae Stock Popped Today ↗

October 02, 2023

Via The Motley Fool

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 02, 2023

Via Benzinga

Frequently Asked Questions

Is Invitae Corporation Common Stock publicly traded?

Yes, Invitae Corporation Common Stock is publicly traded.

What exchange does Invitae Corporation Common Stock trade on?

Invitae Corporation Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Invitae Corporation Common Stock?

The ticker symbol for Invitae Corporation Common Stock is NVTA on the New York Stock Exchange

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.